Ikarian Capital, LLC Eli Lilly & CO Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $533,376 - $735,341	1,227 New	1,227 $659,000
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $1.26 Million - $1.55 Million	-5,677 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $21.5 Million - $27.9 Million	-119,323 Reduced 95.46%	5,677 $1.3 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $20.5 Million - $26.6 Million	125,000 New	125,000 $23.4 Million

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.